Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Elbit Imaging, Ltd. (NASDAQ: EMITF).

Full DD Report for EMITF

You must become a subscriber to view this report.


Recent News from (NASDAQ: EMITF)

ELBIT IMAGING ANNOUNCES COMPLETION OF THE FIRST STAGE FOR THE SALE OF UP TO 50% OF THE SHARE CAPITAL OF ELBIT MEDICAL LTD.
Tel Aviv, Israel, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) (" Elbit " or the " Company ") announced today, further to its press release dated August 8, 2018, (regarding signing a Share Purchase Agreement (" SPA ") with an SPC related to the Exigent Capit...
Source: GlobeNewswire
Date: September, 06 2018 15:50
ELBIT IMAGING ANNOUNCES AN UPDATED EVALUATION REFERRING TO ELBIT MEDICAL TECHNOLOGIES
Tel Aviv, Israel, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press release dated June 28, 2018, that Edison Investment Research (Israel) Ltd. published an updated evaluat...
Source: GlobeNewswire
Date: September, 06 2018 07:42
ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL SUBMITTED CONFIDENTIAL FILINGS AS PART OF PURSUING VARIOUS ALTERNATIVES FOR RAISING CAPITAL
Tel Aviv, Israel, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) (" Elbit " or the " Company ") announced today that Gamida Cell Ltd. (" Gamida "), in which the Company indirectly holds approximately 16% of its issued and paid up share capital (approx. 8% on a ...
Source: GlobeNewswire
Date: August, 31 2018 06:15
ELBIT IMAGING ANNOUNCES THE SIGNING OF AN AGREEMENT FOR THE SALE OF UP TO 50% OF THE SHARE CAPITAL OF ELBIT MEDICAL LTD.
Tel Aviv, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) (" Elbit " or the " Company ") announced today, further to its press release dated July 18, 2018, that it has signed a Share Purchase Agreement (" SPA ") with an SPV related to Exigent Capital Gro...
Source: GlobeNewswire
Date: August, 08 2018 07:19
Elbit Imaging Ltd. Announces that Insightec Receives FDA Approval to Initiate Clinical Study of MR-Guided Focused Ultrasound to Treat Patients with Alzheimer's Disease
TEL AVIV, ISRAEL / ACCESSWIRE / July 26, 2018 / Elbit Imaging Ltd. (TASE: EMITF, NASDAQ: EMITF) (" Elbit " or the " Company ") announced today, further to its press release dated March 27, 2017 that Insightec Ltd. (" Insightec ") informed that the U.S. Food and Drug Administration (FDA) has ...
Source: ACCESSWIRE
Date: July, 26 2018 06:50
Elbit Imaging Announces Several Steps Intended to Strengthen its Financial Position
TEL AVIV, ISRAEL / ACCESSWIRE / July 18, 2018 / Elbit Imaging Ltd. (NASDAQ: EMITF) (TASE: EMITF) (NASDAQ: EMITF) ("Elbit" or the "Company") announced today several steps intended to strengthen its financial position as follows: Non-Binding Memorandum of Understanding for the Sale of a Port...
Source: ACCESSWIRE
Date: July, 18 2018 17:20
Elbit Imaging Announces That Gamida Cell Receives Orphan Drug Designation From the Fda for Nicord® as a Treatment for Hematopoietic Stem Cell Transplantation
Tel Aviv, Israel, July 17, 2018 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today that Gamida Cell Ltd. (" Gamida "), an indirect shareholding of the Company, informed that the U.S. Food and Drug Administrat...
Source: GlobeNewswire
Date: July, 17 2018 08:42
Elbit Imaging Announces Term Sheet In Respect Of A Plot In Chennai, India
TEL AVIV, ISRAEL / ACCESSWIRE / July 5, 2018 / Elbit Imaging Ltd. ("EI" or the "Company") (TASE: EMITF) (NASDAQ: EMITF) announced today, further to its press release dated August 2, 2016 (regarding Elbit Plaza India Real Estate Holdings Limited (" EPI ") (a jointly controlled subsidiary in w...
Source: ACCESSWIRE
Date: July, 05 2018 06:31
Elbit Imaging Ltd. Announces Israeli Court Ruling In Regards to VAT Assessments
TEL AVIV, ISRAEL / ACCESSWIRE / July 2, 2018 / Elbit Imaging Ltd. (TASE: EMITF) (NASDAQ: EMITF) (" Elbit " or the " Company ") announced today that an Israeli court issued a decision in a lawsuit brought by the Company against the Israeli Tax Authority relating to VAT assessments issued to t...
Source: ACCESSWIRE
Date: July, 02 2018 14:30
Elbit Imaging Ltd. Announces Receipt of Nasdaq Continued Listing Deficiency Notice
TEL AVIV, ISRAEL / ACCESSWIRE / June 28, 2018 / Elbit Imaging Ltd. (TASE: EMITF) (NASDAQ: EMITF) (" Elbit " or the " Company ") announced today that that it has received written notification from the Nasdaq Stock Market (" Nasdaq ") dated June 26, 2018, indicating that the Company is no long...
Source: ACCESSWIRE
Date: June, 28 2018 11:42

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-141.741.731.741.73397
2018-12-131.58121.701.701.58121,443
2018-12-121.701.701.701.5727,975
2018-12-111.791.701.871.647334,765
2018-12-101.781.861.861.69742,603

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1420029567.7966Short
2018-12-124002,30517.3536Cover
2018-12-1130010,7272.7967Cover
2018-12-101001,4007.1429Cover
2018-11-30101101100.0000Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EMITF.


About Elbit Imaging, Ltd. (NASDAQ: EMITF)

Logo for Elbit Imaging, Ltd. (NASDAQ: EMITF)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $22,517,480 - 05/15/2018
  • Issue and Outstanding: 9,190,808 - 12/31/2016

 


Recent Filings from (NASDAQ: EMITF)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 16 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 03 2018
Annual and transition report of foreign private issuers under sections 13 or 15(d)
Filing Type: 20-FFiling Source: edgar
Filing Date: April, 27 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 27 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 29 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 22 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 22 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 20 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 20 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 15 2018

 

 


Daily Technical Chart for (NASDAQ: EMITF)

Daily Technical Chart for (NASDAQ: EMITF)


Stay tuned for daily updates and more on (NASDAQ: EMITF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: EMITF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EMITF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EMITF and does not buy, sell, or trade any shares of EMITF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/